Stephen K. Brannan, Chief Medical Officer at Karuna Therapeutics, Inc. (KRTX), sold 11,046 shares at $316.56 ($3.5M) on 2024-02-08, disclosed to the SEC on 2024-02-12.
Scheduled sale ($3.5M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $316.05 | 4,182 | $1.3M | 37.8% |
| 2 | $316.05 | 4,182 | $1.3M | 37.8% |
| 3 | $316.56 | 818 | $259K | 7.4% |
| 4 | $316.56 | 818 | $259K | 7.4% |
| 5 | $317.14 | 1,046 | $332K | 9.5% |
| Total | $316.23 avg | 11,046 |
| $3.5M |
| 100% |
| Filing → |
| KRTX | SELL | 2024-01-09 | $4.8M | — | Filing → |
| KRTX | SELL | 2023-12-12 | $4.0M | — | Filing → |
| KRTX | SELL | 2023-11-13 | $1.7M | — | Filing → |